JPRN-UMIN000007758已完成未知
Pharmacokinetics(PK) study of Peramivir in Epithelial Lining Fluid (ELF), an open-label study. - PK study of Peramivir in ELF
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)History of hypersensitivity caused by lidocaine hydrochloride. 2)History of hypersensitivity caused by neuraminidase inhibitors. 3)In medication. 4)Creatinine clearance >=30mL/min. 5)Smorker. 6)Hepatic or Renal disorder, Anemia proved by the pre-medical test. 7)Any other participants whose condition is inappropriate for the evaluation of this clinical study, judged by the investigator.
研究者
相似试验
已完成
不适用
The virology and clinical effects of peramivir on influenza virus infections in high-risk patients or patients with severe symptoms:an open-label, non-randomized, multi-centre study.Influenza virus infections.JPRN-UMIN000007320Center for Advanced Medical Innovation Kyushu University20
已完成
不适用
Pharmacokinetics(PK) study of meropenem in Epithelial Lining Fluid (ELF), an open-label studyHealthy volunteerJPRN-UMIN000010941Keio University, School of Medicine9
已完成
不适用
Comparison of clinical efficacy between peramivir and oseltamivir for the treatment of influenza in high-risk patientsInfluenza virus infectionJPRN-UMIN000010595Hamamatsu University School of Medicine60
撤回
不适用
Pharmacokinetic Assessment of Peramivir in Hospitalized Adults Undergoing Continuous Renal Replacement TherapyInfluenzaRenal FailureNCT01146353Midwestern University
进行中（未招募）
1 期
A pharmacokinetic study to assess Nevirapine levels in HIV-infected patients with impaired hepatic function.Treatment of HIV infectionEUCTR2005-000175-17-ES60